"We need to increase public understanding of the need for medical counter measures such as a pan corona virus vaccine. A key driver is the media and the economics will follow the hype, we need to use that hype to our advantage to get to the real issues, investors will respond if they see profit at the end of the process."
Independent Investigator / Spike Proteins
Ralph Barrak you can make a lot of money off of this.
73 Patents on All "NOVEL" / 7279327 Recombinated nature of lung virus transferred in 2017-2018 from US Chapel of Health - US Govt Paid for Research
The last 16 months have been a rollercoaster of fears and facts, and we have seen the narrative behind COVID-19 change constantly, it was novel after all, what could we expect?
Dr. Reiner Fuellmich who has been leading the charge on exposing the true information surrounding COVID-19 recently hosted Dr. David Martin, a professional analyst who has shared some disturbing information. His evidence appears very compelling and credible, and I have fact checked some of the patents he has identified. It’s clear COVID-19 was never a novel (new) virus.
Watch this interview in full, hear the testimony of Dr. David Martin and the patents he’s analysed over the last many years. All publicly available going back to 1999 showing the Novel Coronavirus was well known for two decades. He explains his credentials and provides many quotes about how this present outbreak was probably engineered.
It was a surprise to me that we knew about this back in 2000 following a patent application by Miller, Klepfer, Reid and Jones Jan 28 2000 US patent 6372224.
If you are as concerned as I am, I encourage you to share this video, tag your friends, family, and neighbours, encourage them to examine the narrative versus the emerging evidence and put an end to these lockdowns.
Following the money trail that our present virus problems have been manipulated by the US CDC and Chinese. More investigations will be hopefully taken up as Gain of Function Research had been continued and financed by US Interest in China.
A helper cell for producing an infectious, replication defective,coronavirus(or more generally nidovirus) particle cell comprises (a) a nidovirus permissive cell; (b) a nidovirus replicon RNA comprising the nidovirus packaging signal and a heterologous RNA sequence, wherein the replicon RNA further lacks a sequence encoding at least one nidovirus structural protein; and (c) at least one separate helper RNA encoding the at least one structural protein absent from the replicon RNA, the helper RNA(s) lacking the nidovirus packaging signal. The combined expression of the replicon RNA and the helper RNA in the nidovirus permissive cell produces an assembled nidovirus particle which comprises the heterologous RNA sequence, is able to infect a cell, and is unable to complete viral replication in the absence of the helper RNA due to the absence of the structural protein coding sequence in the packaged replicon. Compositions for use in making such helper cells, along with viral particles produced from such cells, compositions of such viral particles, and methods of making and using such viral particles, are also disclosed.